Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study-Reference-Cited by-同舟云学术

Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study

Published:2022-05-06 Issue:3 Volume:11 Page:1101-1116
ISSN:2193-8253
Container-title:Neurology and Therapy
language:en
Short-container-title:Neurol Ther

Author:

Meca-Lallana José E.,Gómez-Ballesteros Rocío^ORCID,Pérez-Miralles Francisco,Forero Lucía,Sepúlveda María,Calles Carmen,Martínez-Ginés María L.,González-Suárez Inés,Boyero Sabas,Romero-Pinel Lucía,Sempere Ángel P.,Meca-Lallana Virginia,Querol Luis,Costa-Frossard Lucienne,Prefasi Daniel,Maurino Jorge

Funder

Roche Farma Spain

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s40120-022-00356-6.pdf

Reference43 articles.

1. Marignier R, Cobo Calvo A, Vukusic S. Neuromyelitis optica and neuromyelitis optica spectrum disorders. Curr Opin Neurol. 2017;30(3):208–15.

2. Weinshenker BG, Wingerchuk DM. Neuromyelitis spectrum disorders. Mayo Clin Proc. 2017;92(4):663–79.

3. Papp V, Magyari M, Aktas O, et al. Worldwide incidence and prevalence of neuromyelitis optica: a systematic review. Neurology. 2021;96(2):59–77.